The latest edition of the Lung-MAP newsletter is out, with (good news) updates on this precision medicine trial testing targeted new treatments for non-small cell lung cancer.

Despite the COVID-19 pandemic, Lung-MAP is going strong with four sub-studies open for patients and more in the pipeline. Get the details by viewing the newsletter here.